Search

Marianne P. Allen

Examiner (ID: 17617, Phone: (571)272-0712 , Office: P/1647 )

Most Active Art Unit
1647
Art Unit(s)
1818, 1812, 1645, 1805, 1631, 1647
Total Applications
2168
Issued Applications
1046
Pending Applications
251
Abandoned Applications
885

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 6939060 [patent_doc_number] => 20050112623 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-26 [patent_title] => 'Bio-cell chip' [patent_app_type] => utility [patent_app_number] => 10/920054 [patent_app_country] => US [patent_app_date] => 2004-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2168 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0112/20050112623.pdf [firstpage_image] =>[orig_patent_app_number] => 10920054 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/920054
Bio-cell chip Aug 16, 2004 Abandoned
Array ( [id] => 7145221 [patent_doc_number] => 20050119165 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-02 [patent_title] => 'Vascular endothelial growth factor dimers' [patent_app_type] => utility [patent_app_number] => 10/917577 [patent_app_country] => US [patent_app_date] => 2004-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 21814 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20050119165.pdf [firstpage_image] =>[orig_patent_app_number] => 10917577 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/917577
Vascular endothelial growth factor dimers Aug 12, 2004 Abandoned
Array ( [id] => 4960524 [patent_doc_number] => 20080274949 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-06 [patent_title] => 'Formulation of Albumin-Free Erythropoietin' [patent_app_type] => utility [patent_app_number] => 10/567475 [patent_app_country] => US [patent_app_date] => 2004-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4376 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0274/20080274949.pdf [firstpage_image] =>[orig_patent_app_number] => 10567475 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/567475
Formulation of Albumin-Free Erythropoietin Jul 26, 2004 Abandoned
Array ( [id] => 6991452 [patent_doc_number] => 20050090489 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-28 [patent_title] => 'Use of a substance which binds to the peripheral benzodiazepine receptor in the treatment of cutaneous stress' [patent_app_type] => utility [patent_app_number] => 10/898793 [patent_app_country] => US [patent_app_date] => 2004-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 4958 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0090/20050090489.pdf [firstpage_image] =>[orig_patent_app_number] => 10898793 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/898793
Use of a substance which binds to the peripheral benzodiazepine receptor in the treatment of cutaneous stress Jul 25, 2004 Abandoned
Array ( [id] => 7233914 [patent_doc_number] => 20050079549 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-14 [patent_title] => 'Methods for modeling GPCRs and for producing ligand blocking and receptor activating antibodies for same' [patent_app_type] => utility [patent_app_number] => 10/897170 [patent_app_country] => US [patent_app_date] => 2004-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 9298 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0079/20050079549.pdf [firstpage_image] =>[orig_patent_app_number] => 10897170 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/897170
Methods for modeling GPCRs and for producing ligand blocking and receptor activating antibodies for same Jul 21, 2004 Abandoned
Array ( [id] => 4971954 [patent_doc_number] => 20070111957 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-17 [patent_title] => 'Synthetic gene encoding human epidermal growth factor 2/neu antigen and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/565418 [patent_app_country] => US [patent_app_date] => 2004-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 13127 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0111/20070111957.pdf [firstpage_image] =>[orig_patent_app_number] => 10565418 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/565418
Synthetic gene encoding human epidermal growth factor 2/neu antigen and uses thereof Jul 19, 2004 Abandoned
Array ( [id] => 8955701 [patent_doc_number] => 08501473 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-08-06 [patent_title] => 'Use of pleitrophin for preventing and treating pancreatic diseases and/or obesity and/or metabolic syndrome' [patent_app_type] => utility [patent_app_number] => 10/564769 [patent_app_country] => US [patent_app_date] => 2004-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 8 [patent_no_of_words] => 18465 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10564769 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/564769
Use of pleitrophin for preventing and treating pancreatic diseases and/or obesity and/or metabolic syndrome Jul 14, 2004 Issued
Array ( [id] => 7206174 [patent_doc_number] => 20050043237 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-24 [patent_title] => 'Pituitary adenylate cyclase activating peptide (PACAP) receptor 3 (R3) agonists and their pharmacological methods of use' [patent_app_type] => utility [patent_app_number] => 10/892981 [patent_app_country] => US [patent_app_date] => 2004-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 18273 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0043/20050043237.pdf [firstpage_image] =>[orig_patent_app_number] => 10892981 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/892981
Pituitary adenylate cyclase activating peptide (PACAP) receptor 3 (R3) agonists and their pharmacological methods of use Jul 14, 2004 Issued
Array ( [id] => 5739234 [patent_doc_number] => 20060009625 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-12 [patent_title] => 'Method for purifying a protein of the cystine-knot superfamily' [patent_app_type] => utility [patent_app_number] => 10/887106 [patent_app_country] => US [patent_app_date] => 2004-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10333 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20060009625.pdf [firstpage_image] =>[orig_patent_app_number] => 10887106 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/887106
Method for purifying a protein of the cystine-knot superfamily Jul 7, 2004 Issued
Array ( [id] => 168410 [patent_doc_number] => 07666841 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-02-23 [patent_title] => 'Peptides with the capacity to bind to transforming growth factor β1 (TGF-β1)' [patent_app_type] => utility [patent_app_number] => 10/569012 [patent_app_country] => US [patent_app_date] => 2004-07-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 7776 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/666/07666841.pdf [firstpage_image] =>[orig_patent_app_number] => 10569012 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/569012
Peptides with the capacity to bind to transforming growth factor β1 (TGF-β1) Jul 4, 2004 Issued
Array ( [id] => 359825 [patent_doc_number] => 07485704 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-02-03 [patent_title] => 'Reducing protein A leaching during protein A affinity chromatography' [patent_app_type] => utility [patent_app_number] => 10/877532 [patent_app_country] => US [patent_app_date] => 2004-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 13 [patent_no_of_words] => 14675 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 95 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/485/07485704.pdf [firstpage_image] =>[orig_patent_app_number] => 10877532 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/877532
Reducing protein A leaching during protein A affinity chromatography Jun 23, 2004 Issued
Array ( [id] => 7206162 [patent_doc_number] => 20050043235 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-24 [patent_title] => 'Use of VEGF-C or VEGF-D in reconstructive surgery' [patent_app_type] => utility [patent_app_number] => 10/868549 [patent_app_country] => US [patent_app_date] => 2004-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 28460 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0043/20050043235.pdf [firstpage_image] =>[orig_patent_app_number] => 10868549 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/868549
Use of VEGF-C or VEGF-D in reconstructive surgery Jun 13, 2004 Abandoned
Array ( [id] => 830276 [patent_doc_number] => 07399830 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-07-15 [patent_title] => 'Synaptic activation protein compositions and method' [patent_app_type] => utility [patent_app_number] => 10/866256 [patent_app_country] => US [patent_app_date] => 2004-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 35 [patent_no_of_words] => 11280 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/399/07399830.pdf [firstpage_image] =>[orig_patent_app_number] => 10866256 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/866256
Synaptic activation protein compositions and method Jun 9, 2004 Issued
Array ( [id] => 7275590 [patent_doc_number] => 20040235041 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-25 [patent_title] => 'Nucleic acids containing single nucleotide polymorphisms and methods of use thereof' [patent_app_type] => new [patent_app_number] => 10/865478 [patent_app_country] => US [patent_app_date] => 2004-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 20707 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0235/20040235041.pdf [firstpage_image] =>[orig_patent_app_number] => 10865478 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/865478
Nucleic acids containing single nucleotide polymorphisms and methods of use thereof Jun 9, 2004 Abandoned
Array ( [id] => 7276289 [patent_doc_number] => 20040235740 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-25 [patent_title] => 'Polypeptides homologous to VEGF and BMPI' [patent_app_type] => new [patent_app_number] => 10/863133 [patent_app_country] => US [patent_app_date] => 2004-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 38691 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0235/20040235740.pdf [firstpage_image] =>[orig_patent_app_number] => 10863133 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/863133
Polypeptides homologous to VEGF and BMPI Jun 7, 2004 Abandoned
Array ( [id] => 5794254 [patent_doc_number] => 20060014935 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-19 [patent_title] => 'Fas ligand derived polypeptides' [patent_app_type] => utility [patent_app_number] => 10/861934 [patent_app_country] => US [patent_app_date] => 2004-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 41 [patent_figures_cnt] => 41 [patent_no_of_words] => 40469 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20060014935.pdf [firstpage_image] =>[orig_patent_app_number] => 10861934 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/861934
FAS ligand derived polypeptides Jun 6, 2004 Issued
Array ( [id] => 5794254 [patent_doc_number] => 20060014935 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-19 [patent_title] => 'Fas ligand derived polypeptides' [patent_app_type] => utility [patent_app_number] => 10/861934 [patent_app_country] => US [patent_app_date] => 2004-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 41 [patent_figures_cnt] => 41 [patent_no_of_words] => 40469 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20060014935.pdf [firstpage_image] =>[orig_patent_app_number] => 10861934 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/861934
FAS ligand derived polypeptides Jun 6, 2004 Issued
Array ( [id] => 6971721 [patent_doc_number] => 20050037431 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-17 [patent_title] => 'Methods and compositions for modulating HGF/Met' [patent_app_type] => utility [patent_app_number] => 10/862192 [patent_app_country] => US [patent_app_date] => 2004-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 29219 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0037/20050037431.pdf [firstpage_image] =>[orig_patent_app_number] => 10862192 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/862192
Methods and compositions for modulating HGF/Met Jun 3, 2004 Abandoned
Array ( [id] => 7318969 [patent_doc_number] => 20040224915 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-11 [patent_title] => 'High affinity vascular endothelial growth factor(VEGF) receptor nucleic acid ligands and inhibitors' [patent_app_type] => new [patent_app_number] => 10/862084 [patent_app_country] => US [patent_app_date] => 2004-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 12377 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0224/20040224915.pdf [firstpage_image] =>[orig_patent_app_number] => 10862084 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/862084
High affinity vascular endothelial growth factor(VEGF) receptor nucleic acid ligands and inhibitors Jun 3, 2004 Abandoned
Array ( [id] => 7375149 [patent_doc_number] => 20040219640 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-04 [patent_title] => 'Polypeptides homologous to VEGFand BMPI' [patent_app_type] => new [patent_app_number] => 10/862134 [patent_app_country] => US [patent_app_date] => 2004-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 38672 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0219/20040219640.pdf [firstpage_image] =>[orig_patent_app_number] => 10862134 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/862134
Polypeptides homologous to VEGF and BMP1 Jun 3, 2004 Issued
Menu